2017
DOI: 10.1039/c7dt03229c
|View full text |Cite|
|
Sign up to set email alerts
|

Colchicine metallocenyl bioconjugates showing high antiproliferative activities against cancer cell lines

Abstract: A series of ferrocenyl and ruthenocenyl conjugates with colchicine bearing a 1,2,3-triazole moiety were synthesized and their anticancer properties were evaluated. We found that the most potent metallocenyl derivatives Rc4 and Rc5 are 6-7 times more cytotoxic toward HepG2 cells, while Fc4 and Fc5 are two times more cytotoxic toward HCT116 cells as colchicine. We also found that compounds Fc4, Fc5, Rc1 and Rc3-Rc5 are able to induce apoptosis, while compound Fc2 arrests mitosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 46 publications
0
15
1
Order By: Relevance
“…Kowalczyk and co-workers synthesized ferrocene/ruthenocene analogues ( 84 – 85 ) of colchicine, an antimitotic compound responsible for apoptosis and cell apoptosis death (Figure ). The compounds were tested for their cytotoxic potencies against a panel of human cancer (Colo205, HCT116, HepG2, MCF-7, and A549) cell lines. It is a compelling case where the metallocene-type (ruthenocene/ferrocene) significantly impacted the cell line specificity.…”
Section: Effect Of Amalgamation Of Ferrocene On Anticancer Activitiescontrasting
confidence: 61%
“…Kowalczyk and co-workers synthesized ferrocene/ruthenocene analogues ( 84 – 85 ) of colchicine, an antimitotic compound responsible for apoptosis and cell apoptosis death (Figure ). The compounds were tested for their cytotoxic potencies against a panel of human cancer (Colo205, HCT116, HepG2, MCF-7, and A549) cell lines. It is a compelling case where the metallocene-type (ruthenocene/ferrocene) significantly impacted the cell line specificity.…”
Section: Effect Of Amalgamation Of Ferrocene On Anticancer Activitiescontrasting
confidence: 61%
“…The 1,2,3‐triazolyl conjugates T1 – 8 were synthesized in Cu‐catalyzed 1,3‐dipolar cycloaddition of azide 5 and ω‐metalocenylacetylenes 7 – 14 according to Scheme 2 by applying a reported procedure [29f] . The required ω‐metallocenylalkynes 8 – 14 were prepared in Friedel–Crafts acylation of ferrocene or ruthenocene with acyl trifluoroacetates generated in situ in the presence of trifluoromethanesulfonic acid according to a reported procedure [29b, 37] . Next, azide 5 reacts with acetylenes 7 – 14 at RT for 3 days in a mixture of tert ‐butanol and water in the presence of Cu I complex with TTTA as a catalyst (freshly prepared form copper(II) sulfate, sodium ascorbate and TTTA [38] ) to give 1,2,3‐triazoles T1 – 8 in 19–79 % yields, isolated by column chromatography on silica.…”
Section: Resultsmentioning
confidence: 99%
“…The cytotoxic activity of metallocenyl derivatives often correlates with their ability to induce reactive oxygen species (ROS) production within the cells [49] . Therefore, we studied the pro‐oxidative potential of the investigated compounds using dihydrorhodamine 123 (DHR123) oxidation assay as described previously [29b] (Figure 6). Neither etoposide nor amino conjugates significantly altered intracellular ROS level compared to control.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Negative proliferation percentage using CFSE-FITC was quantified by flow cytometry. Positive control of the absence of cell proliferation was carried out using colchicine at 10 μ M [ 26 ]. Negative control was performed adding RPMI1640 with 10% fetal bovine serum (FBS) heat-inactivated (57°C, 30 min) in HepG2 culture.…”
Section: Methodsmentioning
confidence: 99%